Cosma (c.f.m. Group)

Italy

Digital Content

Amantadine Hydrochloride

About the Company

AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA ...
AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA approval in 1998. AMSA continues to deliver high-quality pharmaceutical ingredients with a strong focus on innovation, compliance, and customer satisfaction.

01

Amantadine Hydrochloride

Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Attending

Italy

Digital Content

Amsa

AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA approval in 1998. AMSA continues to deliver high-quality pharmaceutical ingredients with a strong focus on innovation, compliance, and customer satisfaction.

About the Company : AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA speci...

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Cosma (C.F.M. Group)

Italy

Digital Content

Amisulpride

About the Company

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export ove...
Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

02

Amisulpride

Italy

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Italy

Digital Content

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

About the Company : Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Amsa

Italy

Digital Content

Bromhexine Hydrochloride

About the Company

AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA ...
AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA approval in 1998. AMSA continues to deliver high-quality pharmaceutical ingredients with a strong focus on innovation, compliance, and customer satisfaction.

03

Bromhexine Hydrochloride

Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Attending

Italy

Digital Content

Amsa

AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA approval in 1998. AMSA continues to deliver high-quality pharmaceutical ingredients with a strong focus on innovation, compliance, and customer satisfaction.

About the Company : AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA speci...

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Cosma (C.F.M. Group)

Italy

Digital Content

Carprofen

About the Company

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export ove...
Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

04

Carprofen

Italy

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Italy

Digital Content

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

About the Company : Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons ...

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Cosma (C.F.M. Group)

Italy

Digital Content

Cetirizine Dihydrochloride

About the Company

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export ove...
Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

05

Cetirizine Dihydrochloride

Italy

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Italy

Digital Content

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

About the Company : Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons ...

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Cosma (C.F.M. Group)

Italy

Digital Content

Cloperastine

About the Company

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export ove...
Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

06

Cloperastine

Italy

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Italy

Digital Content

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

About the Company : Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons ...

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Cosma (C.F.M. Group)

Italy

Digital Content

Cloperastine Fendizoate

About the Company

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export ove...
Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

07

Cloperastine Fendizoate

Italy

Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.

Italy

Digital Content

Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons of annual API output. Originally founded to introduce the CFM group into the U.S. generic market, Cosma was FDA-approved in 1984 and continues to export over 50% of its production to the U.S. Today, Cosma supports leading global generic and branded pharmaceutical companies, while also maintaining a strong presence in the animal health sector. Covering more than 5,000 m², Cosma is recognized for its scale, regulatory excellence, and reliability.

About the Company : Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over 300 tons ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Clarochem Ireland

Italy

Digital Content

Dexketoprofen Trometamol

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company

Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its first US FDA approval in 2017, the site is well-positioned for contract manufacturing opportunities. With ample room for expansion, it plays a strategic role in...
Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its first US FDA approval in 2017, the site is well-positioned for contract manufacturing opportunities. With ample room for expansion, it plays a strategic role in the group’s back-integration of GMP starting materials and intermediates, enhancing efficiency and value across all affiliated companies.

08

Dexketoprofen Trometamol

Ireland

Coatings Trends

Not Confirmed

Italy

Digital Content

Clarochem Ireland

Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its first US FDA approval in 2017, the site is well-positioned for contract manufacturing opportunities. With ample room for expansion, it plays a strategic role in the group’s back-integration of GMP starting materials and intermediates, enhancing efficiency and value across all affiliated companies.

About the Company : Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its firs...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Clarochem Ireland

Italy

Digital Content

Droxidopa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company

Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its first US FDA approval in 2017, the site is well-positioned for contract manufacturing opportunities. With ample room for expansion, it plays a strategic role in...
Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its first US FDA approval in 2017, the site is well-positioned for contract manufacturing opportunities. With ample room for expansion, it plays a strategic role in the group’s back-integration of GMP starting materials and intermediates, enhancing efficiency and value across all affiliated companies.

09

Droxidopa

Ireland

Coatings Trends

Not Confirmed

Italy

Digital Content

Clarochem Ireland

Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its first US FDA approval in 2017, the site is well-positioned for contract manufacturing opportunities. With ample room for expansion, it plays a strategic role in the group’s back-integration of GMP starting materials and intermediates, enhancing efficiency and value across all affiliated companies.

About the Company : Clarochem Ireland, established in 2009 following the acquisition of a state-of-the-art facility in Damastown near Dublin, offers approximately 60,000L of manufacturing capacity. Gaining its firs...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Amsa

Italy

Digital Content

Etodolac

About the Company

AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA ...
AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA approval in 1998. AMSA continues to deliver high-quality pharmaceutical ingredients with a strong focus on innovation, compliance, and customer satisfaction.

10

Etodolac

Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Attending

Italy

Digital Content

Amsa

AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA specializes in the production of small- to medium-volume APIs for both generic and custom synthesis markets. The site holds a 60,000L capacity and earned US FDA approval in 1998. AMSA continues to deliver high-quality pharmaceutical ingredients with a strong focus on innovation, compliance, and customer satisfaction.

About the Company : AMSA S.p.A, founded in 1953 near Italy’s iconic Lake Como, is the founding manufacturing company of the CFM Group. With a modernized facility and over six decades of experience, AMSA speci...